PharmScript founder Saul Greenberger was featured in PADONA August newsletter speaking on the subject of: ” Are Your Dementia Care Efforts on Target?”

On June 3, 2016, CMS released its latest update on the National Partnership to Improve Dementia Care in Nursing Homes. While staff in many nursing facilities have reduced their rate of antipsychotic medication use, CMS reports that others have not been as successful. The official measure used by the National Partnership is the percent of long-stay residents who receive an antipsychotic medication, excluding those with Schizophrenia, Huntington’s disease, or Tourette’s syndrome. Since the effort began collecting data in 2011, the percent of residents receiving an antipsychotic medication has decreased from 23.9% in 2012 to a third quarter 2015 national average of 17.4%, an overall reduction of 27%. As facilities in additional states reach the target goals, usage will drop even lower.

Click here to read the PADONA August Newsletter 2016